J. Anthony Ware's most recent trade in First Tracks Biotherapeutics Inc. was a trade of 28,571 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 28,571 | 28,571 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 10,694 | 10,694 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 9,200 | 9,200 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | J. Anthony Ware | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | J. Anthony Ware | Director | 06 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 06 Jan 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 23 Dec 2025 | 3,900 | 9,630 (0%) | 0% | 49.6 | 193,343 | Common Stock | |
| AnaptysBio Inc | J. Anthony Ware | Director | 15 Jun 2025 | 6,030 | 0 | - | - | Restricted Stock Unit | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 15 Jun 2025 | 6,030 | 13,530 (0%) | 0% | 0 | Common Stock | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 07 Jan 2025 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 07 Jan 2025 | 6,030 | 6,030 | - | - | Restricted Stock Unit | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 15 Jun 2024 | 3,900 | 0 | - | - | Restricted Stock Unit | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 15 Jun 2024 | 3,900 | 7,500 (0%) | 0% | 0 | Common Stock | ||
| AnaptysBio Inc | Ware J. Anthony | Director | 03 Jan 2024 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | ||
| AnaptysBio Inc | Ware J. Anthony | Director | 03 Jan 2024 | 6,030 | 6,030 | - | - | Restricted Stock Unit | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | ||
| AnaptysBio Inc | J. Anthony Ware | Director | 10 Feb 2022 | 9,200 | 9,200 | - | - | Stock Option (right to buy) |